Trinity Biotech plc (TRIB) — Analysis Summary
Trinity Biotech plc (TRIB) has a market cap of $14.23M with year-over-year revenue growth of +8.3%. Net margin stands at -50.7%. The stock trades at a P/E ratio of -0.5.
Key Takeaways
- Revenue changed +8.3% year-over-year
- Net margin of -50.7%
- P/E ratio of -0.5
Compared with its sector, TRIB posted revenue growth of +8.3% and trades at a P/E of -0.5.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.